BME to float 33.1% stake
Article Abstract:
Bolsas & Mercados Espanoles S.A. of Spain is planning an initial public offering. The stock exchange operator is tendering 27.7 million shares or approximately one third of the company. The stock exchange will be valued at approximately 2 billion Euros ($2.5 billion).
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
BME's earnings climb 19%
Article Abstract:
Bolsas & Mercados Espanoles S.A. of Spain posted a soaring 19 percent increase in second quarter net profit to 29.4 million Euros ($37.9 million) from 24.8 million Euros last year. Revenues at the Spanish stock exchange were due to strong trading activity.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Credit Agricole boosts stake in a prized target, Bankinter
Article Abstract:
French banking firm Credit Agricole S.A. increased its stake in Spanish bank Bankinter S.A. to 19.53% in a deal valued at $1.19 bil. The stake represents a 13% premium to Bankinter's market capitalization.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: CME ends Polish foray with sale of TVN stake. Europe's defense firms aim at U.S. Change in rules needed for wake of big new jet
- Abstracts: Serono takes itself off the block. Novartis posts 4.1% rise in earnings. Serono's net profit rises 72% on lower costs
- Abstracts: BMW's sales rev up, but net income stays flat. BMW's earnings rise 17%; new competition may test sales. BMW keeps sector lead as 2007 sales rose 9.2%
- Abstracts: Siemens profit falls 17%, hit by price-fixing fine. Siemens earnings soar; sales rise 14%
- Abstracts: Glaxo plans to trim jobs as profit falls. Glaxo expects earnings to fall in 2008